Trial intelligence / Profile preview

Cilostazol in Diabetic Neuropathy (ASCEND)

NCT01076478Phase 4Completed

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
Mar 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cilostazol in diabetic polyneuropathy (DPN), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Mar 2004; status: completed.

02

Drugs

cilostazol
03

Conditions

diabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on NCT01076478.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01076478.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call